Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Immunohematology
Volume 30 (2014): Issue 2 (June 2014)
Requires Authorization
How we investigate drug-induced immune hemolytic anemia
R.M. Leger
R.M. Leger
American Red Cross Blood Services, Southern California Region
Pomona, CA, United States
Search for this author on
Sciendo
|
Google Scholar
Leger, R.M.
,
P.A. Arndt
P.A. Arndt
American Red Cross Blood Services, Southern California Region
Pomona, CA, United States
Search for this author on
Sciendo
|
Google Scholar
Arndt, P.A.
and
G. Garratty
G. Garratty
American Red Cross Blood Services, Southern California Region
Pomona, CA, United States
Search for this author on
Sciendo
|
Google Scholar
Garratty, G.
Nov 06, 2019
Immunohematology
Volume 30 (2014): Issue 2 (June 2014)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Article Category:
Report
Published Online:
Nov 06, 2019
Page range:
85 - 94
DOI:
https://doi.org/10.21307/immunohematology-2019-102
Keywords
immune hemolytic anemia
,
drugs
,
antibodies
,
drug-treated red blood cells
,
testing in presence of drug
,
penicillin
,
cephalosporin
,
antibiotics
© 2014 R.M. Leger et al., published by Sciendo
